Fundz

Ocean Biomedical, Inc. reported raising $1.04 Million in an initial SEC Form D filing

PUBLIC · OCEAApr 12, 2021

Amount Raised

$1.04 Million

$1.04 Million sold, per SEC Form D (first sale Apr 12, 2021)

Round Type

Seed

New YorkBiotechnology

Quick answer

Ocean Biomedical raised $1.04 Million in a Seed round, dated April 12, 2021. Ocean Biomedical is based in New York, New York, United States.

How much did Ocean Biomedical raise?
Ocean Biomedical raised $1.04 Million in a Seed round on April 12, 2021.
What does Ocean Biomedical do?
Ocean Biomedical is a 21st century biopharma company that partners with leading scientists and research institutions to accelerate the translation of new discoveries into breakthrough medicines.
Where is Ocean Biomedical based and how big is it?
Ocean Biomedical is based in New York, New York, United States.
Who are the decision-makers at Ocean Biomedical?
Fundz holds 1 contact at Ocean Biomedical. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Ocean Biomedical that raised within 45 days of this round, from Fundz verified event records.

  • BIOCURITY PHARMACEUTICALS INC. raised $25K (Pre-Seed) on May 27, 2021.
  • Allarity Therapeutics raised $20M on May 27, 2021.
  • August Bioservices raised an undisclosed amount (Series A) on May 27, 2021.
  • Interius raised $44M on May 27, 2021.
  • Genapsys, Inc. raised $70M (Series D) on May 27, 2021.
  • Clene Nanomedicine raised $9.3M on May 26, 2021.

Who to call at Ocean Biomedical, and when

A new round usually means Ocean Biomedical is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Ocean Biomedical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ocean Biomedical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Ocean Biomedical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Ocean Biomedical

Location

55 CLAVERICK STREET

New York, New York, United States

About

Ocean Biomedical is a 21st century biopharma company that partners with leading scientists and research institutions to accelerate the translation of new discoveries into breakthrough medicines. We're working to bring together the interdisciplinary expertise and resources required to develop a diverse portfolio of pharmaceutical inventions and technologies through preclinical, clinical, and commercial development. We aim to build a continuous pipeline of drug development opportunities through our relationships with universities and medical centers. Our current product candidates are licensed from Brown University, Stanford University, and Rhode Island Hospital. Our pipeline consists of both preclinical and clinical-stage programs. We anticipate moving certain preclinical product candidates in our oncology, fibrosis and/or infectious disease platforms, into the clinic in the next 12 to 18 months. We also expect that our anti-inflammatory product candidates licensed from Stanford, will commence Phase 1 clinical trials for the treatment of symptoms of COVID-19, in the first quarter of 2021. Our programs in oncology and fibrosis are based on discoveries of disease pathways and of related drug targets emerging from pioneering work in the field of chitinase biology by our scientific co-founder, Jack A. Elias, M.D., Dean of Medicine at Brown. In infectious disease we are developing therapeutic and vaccine candidates against malaria, a disease that kills 500,000 children under the age of five globally each year, that infects 200-300 million people annually worldwide, and for which 3.4 billion people worldwide are at risk. Our product candidates in malaria are based on the discovery by Jonathan Kurtis, M.D., Ph.D., Chair of Pathology and Laboratory Medicine and Director of the M.D./Ph.D. Program at Brown, of two novel malaria antigens, PfSEA-1 and PfGARP which have shown a significant reduction in malaria parasites under testing (press links below).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Ocean Biomedical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts4 people are listed at Ocean Biomedical. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Ocean Biomedical's next move

See what Strategic adds

Ocean Biomedical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.